Literature DB >> 11033750

Compliance and psychological reactance in schizophrenia.

A Moore1, W Sellwood, J Stirling.   

Abstract

OBJECTIVES: Non-compliance with neuroleptic medication in schizophrenia is a major cause of relapse. A number of sociodemographic variables, and illness, attitudinal and treatment variables, have been demonstrated to be associated with non-compliance. The present study examined a range of these variables and their predictive value in determining past and current compliance.
METHODS: Thirty-nine patients suffering from schizophrenia and three patients suffering from schizoaffective disorder completed a series of questionnaires assessing psychological reactance, insight, subjective response to medication, perceived threat to freedom of choice, and degree of current and past compliance. Logistic regression analyses were performed to determine which factors best predicted past and current compliance.
RESULTS: Psychological reactance and age were found to be the best predictors of past compliance, with an interaction between reactance and perceived threat to freedom of choice posed by treatment provision also making a significant contribution. Past compliance behaviour and subjective response to medication predicted current compliance most significantly.
CONCLUSIONS: Reactance is an important predictor of compliance history especially when patients perceive treatment to be a threat to freedom of choice. Subjective response to neuroleptics is most important in predicting current compliance. Implications for intervention are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033750     DOI: 10.1348/014466500163293

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  9 in total

Review 1.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

2.  Medicines concordance in clinical practice.

Authors:  Abilio C de Almeida Neto; Parisa Aslani
Journal:  Br J Clin Pharmacol       Date:  2008-07-28       Impact factor: 4.335

3.  Competing for patients: an ethical framework for recruiting patients with brain tumors into clinical trials.

Authors:  George M Ibrahim; Caroline Chung; Mark Bernstein
Journal:  J Neurooncol       Date:  2011-02-12       Impact factor: 4.130

4.  Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.

Authors:  Mamta Sapra; Ipsit V Vahia; Pia N Reyes; Paul Ramirez; Carl I Cohen
Journal:  Schizophr Res       Date:  2008-10-11       Impact factor: 4.939

5.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

6.  Treatment modality preferences and adherence to group treatment for panic disorder with agoraphobia.

Authors:  Michel Perreault; Dominic Julien; Noé Djawn White; Claude Bélanger; André Marchand; Theodora Katerelos; Diana Milton
Journal:  Psychiatr Q       Date:  2014-06

7.  Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America.

Authors:  Rogelio Apiquian; Rodrigo Córdoba; Mario Louzã
Journal:  Neuropsychiatr Dis Treat       Date:  2010-12-22       Impact factor: 2.570

8.  To what extent is treatment adherence of psychiatric patients influenced by their participation in shared decision making?

Authors:  Carlos De Las Cuevas; Wenceslao Peñate; Luis de Rivera
Journal:  Patient Prefer Adherence       Date:  2014-11-04       Impact factor: 2.711

9.  Shared decision making, aggression, and coercion in inpatients with schizophrenia.

Authors:  Johannes Hamann; Miriam John; Fabian Holzhüter; Spyridon Siafis; Peter Brieger; Stephan Heres
Journal:  Eur Psychiatry       Date:  2020-09-28       Impact factor: 5.361

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.